Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 0250641 Publication Model: Print Cited Medium: Internet ISSN: 1943-7730 (Electronic) Linking ISSN: 00075027 NLM ISO Abbreviation: Lab Med Subsets: MEDLINE
    • Publication Information:
      Publication: Oct. 2015- : Oxford, England: Oxford University Press
      Original Publication: Philadelphia, Lippincott.
    • Subject Terms:
    • Abstract:
      Objective: Reflex cryptococcal antigen (CrAg) screening of blood specimens with a CD4 count of <100 cells/µL was performed at 45 South African CD4 laboratories using a lateral flow assay (LFA). Our objective was to evaluate the reliability of routine LFA results through comparative interlaboratory testing.
      Methods: All CrAg-positive and a selected number of CrAg-negative samples from the CD4 laboratories were retested at paired microbiology laboratories using the same LFA. Samples with discordant results were tested at a reference laboratory, using the LFA (with CrAg titers).
      Results: During interlaboratory testing, 12,502 samples were retested, with 93 (0.7%) discordant results and a between-laboratory agreement of 99.3% (Cohen's kappa, 0.98). The proportion of retested samples with discordant results ranged from 0.17% to 5.31% per laboratory pair (median 0.28%), with 3 reporting >3% of results as discordant.
      Conclusion: Routine CrAg screening results were reliable, with <1% of samples having discordant results, mainly due to interpretation and transcription errors.
      (© The Author(s) 2022. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: [email protected].)
    • References:
      Clin Infect Dis. 2011 Aug;53(4):321-5. (PMID: 21810743)
      South Afr J HIV Med. 2019 Nov 08;20(1):1030. (PMID: 32201629)
      PLoS One. 2018 Jun 12;13(6):e0198993. (PMID: 29894509)
      S Afr Med J. 2018 Jun 26;108(7):534-535. (PMID: 30004338)
      Afr J Lab Med. 2018 Oct 11;7(1):757. (PMID: 30349807)
      Afr J Lab Med. 2018 Jun 28;7(1):665. (PMID: 30167387)
      Clin Vaccine Immunol. 2013 Jan;20(1):52-5. (PMID: 23114703)
      J Biomed Inform. 2019 Jul;95:103208. (PMID: 31078660)
      Cytometry B Clin Cytom. 2008;74 Suppl 1:S69-79. (PMID: 18228560)
      Clin Infect Dis. 2011 Nov;53(10):1019-23. (PMID: 21940419)
      Cytometry B Clin Cytom. 2008;74 Suppl 1:S40-51. (PMID: 18228554)
      PLoS One. 2016 Jul 08;11(7):e0158986. (PMID: 27390864)
      J Clin Microbiol. 2014 Dec;52(12):4172-5. (PMID: 25232153)
    • Grant Information:
      R01 AI118511 United States AI NIAID NIH HHS; CDC-RFA-GH15-1575 United States CC CDC HHS; R01AI118511 United States NH NIH HHS; CDC-RFA-GH15-1575 US Centers for Disease Control and Prevention
    • Contributed Indexing:
      Keywords: advanced HIV disease; cryptococcal antigen; cryptococcal meningitis; discordant results; interlaboratory comparison; lateral flow assay
    • Accession Number:
      0 (Antigens, Fungal)
    • Publication Date:
      Date Created: 20220606 Date Completed: 20221104 Latest Revision: 20230606
    • Publication Date:
      20240829
    • Accession Number:
      PMC9631796
    • Accession Number:
      10.1093/labmed/lmac037
    • Accession Number:
      35660925